Roman Butler Fullerton & Co’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.1M | Sell |
13,455
-3,318
| -20% | -$937K | 0.98% | 18 |
|
|
2026
Q1 | $4.66M | Buy |
16,773
+332
| +2% | +$91.9K | 1.28% | 13 |
|
|
2025
Q4 | $4.61M | Buy |
16,441
+89
| +0.5% | +$25K | 1.21% | 13 |
|
|
2025
Q3 | $4.89M | Buy |
16,352
+2,370
| +17% | +$701K | 1.31% | 12 |
|
|
2025
Q2 | $4.14M | Sell |
13,982
-34
| -0.2% | -$11K | 1.22% | 16 |
|
|
2025
Q1 | $4.61M | Sell |
14,016
-122,935
| -90% | -$37M | 1.79% | 11 |
|
|
2024
Q4 | $4.26M | Buy |
136,951
+120,819
| +749% | +$38.5M | 1.35% | 17 |
|
|
2024
Q3 | $5.63M | Buy |
16,132
+4
| +0% | +$1.38K | 1.69% | 9 |
|
|
2024
Q2 | $5.32M | Buy |
16,128
+3,474
| +27% | +$1.2M | 1.72% | 10 |
|
|
2024
Q1 | $4.47M | Buy |
12,654
+3,347
| +36% | +$1.1M | 1.68% | 10 |
|
|
2023
Q4 | $2.77M | Buy |
9,307
+3,539
| +61% | +$1.03M | 1.08% | 24 |
|
|
2023
Q3 | $1.76M | Sell |
5,768
-330
| -5% | -$94.1K | 0.83% | 30 |
|
|
2023
Q2 | $1.78M | Buy |
6,098
+260
| +4% | +$67.7K | 0.82% | 28 |
|
|
2023
Q1 | $1.48M | Buy |
5,838
+3,607
| +162% | +$1.05M | 0.74% | 32 |
|
|
2022
Q4 | $703K | Sell |
2,231
-150
| -6% | -$47.5K | 0.36% | 83 |
|
|
2022
Q3 | $693K | Buy |
2,381
+32
| +1% | +$9.01K | 0.44% | 72 |
|
|
2022
Q2 | $644K | Buy |
2,349
+8
| +0.3% | +$2.06K | 0.36% | 83 |
|
|
2022
Q1 | $561K | Sell |
2,341
-66
| -3% | -$15.5K | 0.26% | 102 |
|
|
2021
Q4 | $553K | Buy |
2,407
+8
| +0.3% | +$1.7K | 0.24% | 105 |
|
|
2021
Q3 | $491K | Sell |
2,399
-29
| -1% | -$6.31K | 0.23% | 110 |
|
|
2021
Q2 | $576K | Sell |
2,428
-28
| -1% | -$6.99K | 0.28% | 96 |
|
|
2021
Q1 | $628K | Sell |
2,456
-136
| -5% | -$30.3K | 0.31% | 98 |
|
|
2020
Q4 | $540K | Sell |
2,592
-5,094
| -66% | -$999K | 0.32% | 92 |
|
|
2020
Q3 | $1.3M | Sell |
7,686
-148
| -2% | -$26.1K | 0.85% | 32 |
|
|
2020
Q2 | $1.47M | Sell |
7,834
-1,649
| -17% | -$313K | 1.05% | 24 |
|
|
2020
Q1 | $1.68M | Buy |
9,483
+888
| +10% | +$172K | 1.48% | 14 |
|
|
2019
Q4 | $1.76M | Sell |
8,595
-478
| -5% | -$87.6K | 1.16% | 18 |
|
|
2019
Q3 | $1.38M | Buy |
9,073
+231
| +3% | +$37.6K | 0.95% | 25 |
|
|
2019
Q2 | $1.39M | Buy |
8,842
+642
| +8% | +$101K | 0.94% | 24 |
|
|
2019
Q1 | $1.32M | Sell |
8,200
-95
| -1% | -$17.4K | 0.92% | 24 |
|
|
2018
Q4 | $1.59M | Buy |
+8,295
| New | +$1.73M | 1.35% | 14 |
|
Other funds holding CI
Roman Butler Fullerton & Co's CI Position: Q2 2026 in Review
Roman Butler Fullerton & Co reduced its Cigna (CI) stake by 20% in Q2 2026, selling an estimated $937K and leaving 13,455 shares worth $4.1M. The position accounts for 0.98% of the portfolio, ranked #18.
Roman Butler Fullerton & Co first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.63M in Q3 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Roman Butler Fullerton & Co held 13,455 shares of Cigna worth $4.1M as of Q2 2026.
- Roman Butler Fullerton & Co sold 3,318 Cigna shares in Q2 2026, an estimated $937K.
- Cigna made up 0.98% of Roman Butler Fullerton & Co's portfolio in Q2 2026, its #18 holding.
- Roman Butler Fullerton & Co first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- Roman Butler Fullerton & Co's Cigna position peaked at $5.63M in Q3 2024.
- 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.